StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
ResMed (RMD:AU) (RMD) PT Raised to AUD21.50 at CLSA
October 26, 2020 8:17 AM
CLSA analyst Hashan De Silva ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Intl Ratings